Pasar al contenido principal

RESPUESTAS DE ADAPTACION AL ESTRES SOBRE LA PARED CELULAR FUNGICA: PROGRAMAS TRANSCRIPCIONALES, DIANAS EFECTORAS Y MECANISMOS DE REGULACION

PID2022-136888NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

mRNA decapping activator Pat1 Is required for efficient yeast adaptive transcriptional responses via the cell wall integrity MAPK pathway

  • Pulido Sanz, Verónica
  • Rodríguez Peña, José Manuel
  • Alonso, Graciela
  • Sanz Santamaría, Ana Belén
  • Arroyo Nombela, Francisco Javier
  • García Sánchez, Raúl
Cellular mRNA levels, particularly under stress conditions, can be finely regulated by the coordinated action of transcription and degradation processes. Elements of the 5′-3′ mRNA degradation pathway, functionally associated with the exonuclease Xrn1, can bind to nuclear chromatin and modulate gene transcription. Within this group are the so-called decapping activators, including Pat1, Dhh1, and Lsm1. In this work, we have investigated the role of Pat1 in the yeast adaptive transcriptional response to cell wall stress. Thus, we demonstrated that in the absence of Pat1, the transcriptional induction of genes regulated by the Cell Wall Integrity MAPK pathway was significantly affected, with no effect on the stability of these transcripts. Furthermore, under cell wall stress conditions, Pat1 is recruited to Cell Wall Integrity-responsive genes in parallel with the RNA Pol II complex, participating both in pre-initiation complex assembly and transcriptional elongation. Indeed, strains lacking Pat1 showed lower recruitment of the transcription factor Rlm1, less histone H3 displacement at Cell Wall Integrity gene promoters, and impaired recruitment and progression of RNA Pol II. Moreover, Pat1 and the MAPK Slt2 occupied the coding regions interdependently. Our results support the idea that Pat1 and presumably other decay factors behave as transcriptional regulators of Cell Wall Integrity-responsive genes under cell wall stress conditions.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Broad protection against Invasive fungal disease from a nanobody targeting the active site of fungal β-1,3-glucanosyltransferases

  • Redrado, Sergio
  • Macías León, Javier
  • Castro-López, Jorge
  • Sanz, Ana Belén
  • Dolader, Elena
  • Arias, Maykel
  • González Ramírez, Andrés Manuel
  • Sánchez-Navarro, David
  • Petryk, Yuliya
  • Farkaš, V.
  • Vincke, Cécile
  • Muyldermans, Serge
  • García Barbazán, Irene
  • Agua, Celia del
  • Zaragoza, Óscar
  • Arroyo, Javier
  • Pardo, Julián
  • Gálvez Buerba, Eva Mª
  • Hurtado-Guerrero, R.
9 figures.-- Supplementary information available.-- Atomic coordinate files and structure factors have been deposited in the Protein DataBank (PDB) with accession codes 8PE2 (dGel4-Nb3 complex) and 8PE1 (dGel4-Nb4 complex). Data collection and refinement statistics are presented in Table S2 of the supplementary information., Invasive fungal disease accounts for about 3.8 million deaths annually, an unacceptable rate that urgently prompts the discovery of new knowledge-driven treatments. We report the use of camelid single-domain nanobodies (Nbs) against fungal β-1,3-glucanosyltransferases (Gel) involved in β-1,3-glucan transglycosylation. Crystal structures of two Nbs with Gel4 from Aspergillus fumigatus revealed binding to a dissimilar CBM43 domain and a highly conserved catalytic domain across fungal species, respectively. Anti-Gel4 active site Nb3 showed significant antifungal efficacy in vitro and in vivo prophylactically and therapeutically against different A. fumigatus and Cryptococcus neoformans isolates, reducing the fungal burden and disease severity, thus significantly improving immunocompromised animal survival. Notably, C. deneoformans (serotype D) strains were more susceptible to Nb3 and genetic Gel deletion than C. neoformans (serotype A) strains, indicating a key role for β-1,3-glucan remodelling in C. deneoformans survival. These findings add new insight about the role of β-1,3-glucan in fungal biology and demonstrate the potential of nanobodies in targeting fungal enzymes to combat invasive fungal diseases., We thank ARAID, CIBERINFEC (CB21-13-0087 and CB21/13/00105, IS Carlos III, Spain), the Slovak Grant Agency for Science (VEGA), Ministry of Science, Innovation and Universities and Agencia Estatal de Investigación, Spain (BIO2016-79289-P, PID2019-105223GB-I00/AEI/10.13039/501100011033, PID2022-136888NB-I00/AEI/10.13039/501100011033, CTQ2013-44367-C2-2-P, BFU2016-75633-P, PID2019-105451GB-I00, SAF2017-83120-C2-1-R, PID2020-113963RB-I00, PID2020-114546RB-I00 and PID2022-136362NB-I00), Comunidad Autónoma de Madrid (CAM) (S2017/BMD3691-InGEMICS-CM), ASPANOA and Gobierno de Aragón (B29_17R, E34_R17, LMP58_18 and LMP139_21) with FEDER (2014-2020) funds for ‘Building Europe from Aragón’ for financial support. The research leading to these results has also received funding from the FP7 (2007-2013) under BioStruct-X (grant agreement No. 283570 and BIOSTRUCTX_5186). M.A. was supported by a post-doctoral fellowship “Juan de la Cierva-formación” (FJCI-2017-31629), J.C.-L. and I.G.-B. were supported by FPI fellowships from Ministerio de Ciencia e Innovación, and J.M.-L. and S.R. by a predoctoral fellowship from Gobierno de Aragón. We thank a crowdfunding initiative through the platform Precipita (Nanofungi) for funding support., Peer reviewed